Six months after expanding into Guatemala, Immunotec has officially opened for business in Colombia.
A grand opening event was recently held in the heart of Bogotá, Colombia’s capital city, attracting over 4,000 enthusiastic attendees. Immunotec CEO Mauricio Domenzain and Meredith Berkich, president of North America and Europe, attended the event.
“We’re tremendously excited to bring the Immunotec opportunity to the people of Colombia,” said Domenzain. “Their legendary warmth, passion and enthusiasm was on full display at our event. The entire Immunotec team and our field leaders are so proud to open up for business in Colombia. It’s a market I’ve always believed was perfect for Immunotec and our flagship product, Immunocal. Now we are here, and I cannot wait to see the energy that lit up our launch event change lives across the country.”
Domenzain led the private equity purchase of Immunotec that was completed in June 2017 (the company had been publicly traded on Canada’s TSX Venture Stock Exchange since 2007) and has made key changes to corporate leadership, including the recent addition of seasoned industry executives Mario Leyva as vice president of Latin America and director of Mexico, and Connie Galofre as country manager for Colombia.
Founded in 1996 with offices in Montreal, Mexico City and Houston, Immunotec now has a network of independent consultants in Canada, the Dominican Republic, Guatemala, Ireland, Mexico, the United Kingdom and the United States. The company plans to continue the momentum with expansion into other Latin American markets in 2019.
